2型糖尿病患者抗炎治疗前后相关指标分析

目的探讨2型糖尿病（T2DM）患者血清脂联素（APN）与炎性因子的相关性，并观察抗炎药物对糖尿病患者的疗效。方法将2型糖尿病患者分为T2DM合并血管病变组（A组）53例，T2DM无血管病变组（B组）47例，以健康人30例为对照组。分别检测抗炎治疗前后各组胰岛素、糖化血红蛋白（HbAlc）、血脂（1ipids）、游离脂肪酸（FFA）、C-反应蛋白（CRP）、APN、瘦素（Leptin）及肿瘤坏死因子（TNF-α）、胰岛素敏感性指数（ISI）及胰岛素抵抗指数（IR）等。结果ISI、IR、FFA、CRP、APN、Leptin、TNF-α含量均高于对照组（均P〈0．05）；抗炎治疗后明显下降（均P〈0．05）；APN平与HbAlc、HOMA-IR、CRP及TNF—α呈显著负相关（均P〈0．05）。结论APN是T2DM和动脉粥样硬化的保护性因子，抗炎治疗可能改善T2DM的预后。

The relevant indicators of anti-inflammatory treatment In patients with type 2 diabetes

Objective To investigate the correlation between serum adiponectin level and inflammatory factors in patients with type 2 diabetes mellitus(T2DM).Methods In our hospital out-patient and patients with T2DM were divided into combined macrovascular T2DM group(A group) 53 cases;T2DM without macroangi-opathy group(Bgroup) 47 cases;30 cases of healthy people as control group.The contents of insulin,glycosylated hemoglobin (HbAIc),blood lipids,free fatty acids(FFA),C-reactive protein(CRP),adiponectin(APN),leptin and tumor necrosis factor(TNF-α),insulin sensitivity index(ISI) and insulin resistance index(IR) were detected.Results ISI,IR,FFA,CRP,APN,Leptin,TNF-α levels were higher(P<0.05);anti-inflammatory treatment was significantly decreased(all P<0.05);APN level and HbAlc,HOMA-IR,CRP,TNF-α was significantly negatively correlated(P<0.05).Conclusion APN is a T2DM and atheroscherosis protection factor,anti-inflammatory treatment may improve the prognosis of T2DM.